Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Golden berry seed extract is a bioactive lipid fraction derived from the seeds of *Physalis peruviana*, a plant native to the high-altitude regions of the Andes. The extract is characterized by a high concentration of essential fatty acids, particularly linoleic acid (omega-6), and is a rich source of phytosterols (such as beta-sitosterol, campesterol, and stigmasterol) and tocopherols (Vitamin E). In biotechnology and nutritional science, it is valued for its potent antioxidant and anti-inflammatory properties. The mechanism of action involves the neutralization of reactive oxygen species (ROS) by tocopherols and the modulation of inflammatory signaling pathways by phytosterols and withanolides, which may inhibit pro-inflammatory enzymes like cyclooxygenase-2 (COX-2). It is primarily utilized as a dietary supplement for cardiovascular and metabolic health and as a topical agent in dermatological formulations to enhance skin barrier function and protect against oxidative damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on golden berry seed extract.